| US 7,563,458 B2 | ||
| Nutritional compositions for nutritional management of patients with liver disease | ||
| Hisae Kume, Kanagawa (Japan); Makoto Yamaguchi, Kanagawa (Japan); Kenji Mizumoto, Kanagawa (Japan); and Hajime Sasaki, Kanagawa (Japan) | ||
| Assigned to Meiji Dairies Corporation, Tokyo (Japan) | ||
| Appl. No. 10/535,585 PCT Filed Nov. 21, 2003, PCT No. PCT/JP03/14918 § 371(c)(1), (2), (4) Date Aug. 10, 2005, PCT Pub. No. WO2004/047566, PCT Pub. Date Jun. 10, 2004. |
||
| Claims priority of application No. 2002-339948 (JP), filed on Nov. 22, 2002. | ||
| Prior Publication US 2006/0073186 A1, Apr. 06, 2006 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. A61K 35/20 (2006.01) | ||
| U.S. Cl. 424—535 | 23 Claims |
| 1. A liquid nutritional composition for liver disease patients comprising:
a) protein, wherein the protein comprises a whey protein isolate (WPI) hydrolysate in an amount of 0.9 to 3 g per 100 mL of
the composition and protein derived from fermented milk in an amount of 2.5 to 4.5 g per 100 mL of the composition;
b) lipids, wherein the lipids comprise an oleic acid-containing oil and lecithin, wherein the lecithin is milk lecithin or
soybean lecithin, or both; and
c) carbohydrate, wherein the carbohydrate comprises palatinose in an amount of 4 to 15 g per 100 mL of the composition.
|